Stem cell and wellness IV protocols are designed to deliver regenerative factors, vitamins and antioxidants intravenously, helping support cellular repair, immune balance and overall vitality in adults seeking longevity care.
Stem Cell and Wellness IV Therapy is an intravenous protocol that combines regenerative biologic factors with high-dose vitamins, amino acids and antioxidants to support cellular repair, immune modulation and energy metabolism. It is typically used by adults focused on longevity, post-illness recovery, fatigue management and general anti-aging support, and is administered in a clinical setting by an experienced aesthetic team after medical screening. A single session generally lasts 60 to 90 minutes, and many programs recommend a short course rather than a one-off treatment. According to the KHIDI 2025 Medical Tourism Survey and OECD Health at a Glance 2024, the Korea market range is $1800-$1800 USD, while the global average is $2400 USD per session, making Korea a competitive destination for regenerative wellness.
Heterogeneous cell mixture isolated from adipose tissue, including pre-adipocytes and mesenchymal-lineage cells; in Korea permitted for limited autologous cosmetic indications under MFDS oversight.
Derived from the same individual receiving the treatment; in regenerative medicine this distinction influences regulatory classification and immunological risk profile.
Derived from a donor other than the recipient; in Korea allogeneic stem cell therapies are restricted to MFDS-approved clinical trials.
Multipotent stromal cell with reported differentiation and paracrine signaling properties; clinical applications remain largely investigational.
Nanoscale extracellular vesicle secreted by cells; in Korea cosmetic-grade exosome products are not equivalent to therapeutic biologics and must avoid disease-treatment claims.
Coenzyme involved in cellular redox reactions; intravenous administration is offered as a wellness service without MFDS efficacy approval.
| Timeline | What to Expect |
|---|---|
| Treatment day; mild erythema common. | |
| Surface response settles; routine resumed. | |
| Early collagen remodeling visible. | |
| Full outcome consolidation captured. |
| Name | Modality | Korean MFDS Status | Typical Session Time | Expected Response Window | Market Price (USD) |
|---|---|---|---|---|---|
| Autologous Adipose-Derived SVF (Stromal Vascular Fraction) | Cell-based, autologous | Permitted for limited cosmetic indications under MFDS oversight | 60-120 min (including liposuction harvest) | 8-16 weeks (preliminary data; outcomes vary) | $3,500-$7,500 |
| Allogeneic Stem Cell Therapy | Cell-based, donor-derived | Restricted to MFDS-approved clinical trials only | Trial-protocol dependent | Investigational; outcomes not generalizable | Not commercially available |
| Exosome-Based Wellness Adjunct | Cell-derived signal molecules (cosmetic-grade) | Cosmetic-grade only; therapeutic disease-treatment claims restricted | 30-45 min | Short-term skin-quality endpoints in studies; evidence preliminary | $300-$900 |
| NAD+ Intravenous Therapy | Coenzyme infusion (wellness) | Off-label wellness administration; no MFDS efficacy approval | 60-180 min | Subjective energy reports in preliminary studies | $250-$800 |
| Glutathione IV Push | Antioxidant infusion (wellness) | Off-label wellness; FDA has issued cautionary statements on whitening claims | 15-30 min | Variable; evidence base limited | $80-$220 |
| Myers' Cocktail (Multivitamin IV) | Vitamin/mineral infusion (wellness) | Off-label wellness administration | 30-45 min | Subjective hydration/energy reports; evidence limited | $120-$300 |
| High-Dose Vitamin C IV | Antioxidant infusion (wellness) | Off-label wellness; investigational in select oncology research | 45-90 min | Outcome data preliminary | $150-$400 |
The summaries below draw on peer-reviewed studies covering device class, efficacy endpoints, and adverse-event profile within this category.
Bora P, Majumdar AS. Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation. Stem Cell Res Ther. 2017;8(1):145. doi:10.1186/s13287-017-0598-y
Guo J, Nguyen A, Banyard DA, et al. Stromal vascular fraction: A regenerative reality? Part 2: Mechanisms of regenerative action. J Plast Reconstr Aesthet Surg. 2016;69(2):180-188. doi:10.1016/j.bjps.2015.10.014
Rajman L, Chwalek K, Sinclair DA. Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell Metab. 2018;27(3):529-547. doi:10.1016/j.cmet.2018.02.011
Pizzorno J. Glutathione! Integr Med (Encinitas). 2014;13(1):8-12. PMID:26770075
Padayatty SJ, Sun AY, Chen Q, Espey MG, Drisko J, Levine M. Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One. 2010;5(7):e11414. doi:10.1371/journal.pone.0011414
Information only, not medical advice. SVF is a heterogeneous cell mixture isolated from a patient's own adipose tissue. Within Korea, MFDS permits autologous adipose-derived SVF for a narrow set of cosmetic indications when administered by licensed physicians; allogeneic stem cell therapies remain restricted to MFDS-approved clinical trials. Studies suggest preliminary biologic activity, but outcomes vary.
Information only, not medical advice. International market averages for autologous adipose-derived SVF procedures range from approximately $3,500 to $7,500 USD, while wellness IV programs commonly fall between $80 and $800 USD per session. Pricing varies by modality, session count, lab processing, and aftercare. KHIDI 2025 indicates Korea typically falls below the global average.
Information only, not medical advice. Preliminary data on autologous SVF point to an 8 to 16 week observation window for cosmetic endpoints, while wellness IV sessions are commonly described in terms of subjective short-term reports. Outcomes depend on the individual and on adherence to post-care guidance; no specific duration can be promised.
Information only, not medical advice. Recovery typically involves mild swelling and bruising at the donor and treatment areas. Studies suggest most patients return to non-strenuous routines within several days, while strenuous activity is commonly deferred for one to two weeks. Hydration, gentle mobility, and follow-up visits are standard aftercare guidance; outcomes vary individually.
Information only, not medical advice. NAD+ infusions are positioned around cellular energy and metabolic support, while glutathione is presented as an antioxidant infusion. Neither carries an MFDS approval for treating a specific disease, and regulators including the FDA have cautioned against marketing whitening claims for glutathione. Evidence remains limited and preliminary.
Information only, not medical advice. NIH guidance indicates that nutrient infusions are not a substitute for adequate diet, hydration, and rest. Wellness IVs may be used adjunctively for elective hydration or convenience, but they are not positioned as treatments for disease and should not replace foundational lifestyle measures. Outcomes vary individually.
Information only, not medical advice. MFDS distinguishes between cosmetic, wellness, and therapeutic categories. Autologous adipose-derived SVF for cosmetic indications operates under specific provisions, allogeneic stem cell therapy requires approved clinical trials, and IV wellness drips are not authorized as disease treatments. Patients are encouraged to verify category and licensing before consenting.
Information only, not medical advice. Exosomes are extracellular vesicles, not whole cells, and Korean cosmetic-grade exosome offerings are categorized separately from cell therapy. Therapeutic disease-treatment claims are restricted under MFDS framing, and outcomes from cosmetic-grade products should not be presented as equivalent to investigational biologic research.
Information only, not medical advice. Regulatory bodies including the US FDA and the Korean MFDS have not approved intravenous glutathione for skin whitening. Marketing such claims is restricted under Article 56(4) of the Medical Service Act, and evidence remains limited and preliminary. Patients should treat any whitening promise as a regulatory risk indicator.
Information only, not medical advice. Standard steps include lipoaspiration, enzymatic digestion, centrifugation, and reinjection within a closed-system protocol. Regulated facilities follow lab-handling SOPs aligned with MFDS guidance. Studies suggest closed-system processing may reduce contamination risk; safety still depends on operator competence and adherence to written procedures.
Have questions about protocols, pricing or timing for your visit to Korea? Our coordinators can review your goals and share a personalized plan. Message us on WhatsApp for a fast, English-friendly response and a free preliminary consultation.
Connect with verified Korean aesthetic specialists. Submit your inquiry and our multilingual coordinators will match you with a procedure plan, transparent pricing breakdown, and an appointment slot that fits your travel schedule. No obligation, no pressure — just clear, evidence-based information.
All fields marked * are required. Your details stay private.